MINNEAPOLIS--(BUSINESS WIRE)--Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT), today announced its schedule of events for Transcatheter Cardiovascular Therapeutics (TCT) 2010, which takes place Sept. 21–25 in Washington, D.C.
